Investigating γ H2AX as a Biomarker of Radiosensitivity Using Flow Cytometry Methods

Table 1

Clinical features of control and radiosensitive groups.

Clinical group	Age at diagnosis; (mean and range)	Preexisting cardiovascular disease/hypertension	Preexisting type II diabetes	Smoker/exsmoker	Mean follow-up time posttreatment (years)	Mean time to onset of Grade 3 proctitis (range)
Control	69 (60–77)	8/20	3/20	8/20	6	N/A
Radiosensitive	73 (68–76)	6/10	1/10	4/10	7	21 months; (9–41 months)